|
![]() |
|||
|
||||
OverviewReviews the artificial heart program - and in particular, the National Institutes of Health's major investment - raising important questions. This volume includes a consideration of the artificial heart versus heart transplantation and other approaches to treating end-stage heart disease, keeping in mind the outcomes and costs of these treatments. Full Product DetailsAuthor: Institute of Medicine , Division of Health Care Services , Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute , Malin VanAntwerpPublisher: National Academies Press Imprint: National Academies Press Dimensions: Width: 15.20cm , Height: 2.50cm , Length: 22.90cm Weight: 0.676kg ISBN: 9780309045322ISBN 10: 0309045320 Pages: 312 Publication Date: 01 February 1991 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of Contents1 Front Matter; 2 Executive Summary; 3 1. The Artificial Heart Program: Current Status and History; 4 2. Total Artificial Hearts: Technological Potential and Research and Development Costs; 5 3. Decisions for Future Research and Development; 6 4. Clinical Effectiveness and Need for Long-Term Circulatory Support; 7 5. Quality of Life and Mechanical Circulatory Support Systems; 8 6. Cost-Effectiveness Analysis; 9 7. The Appropriate Use of Technology; 10 8. Ethical and Societal Issues; 11 9. Roles of Government and Industry in Medical Technology Research, Development and Use; 12 10. Conclusions and Recommendations; 13 Appendix A: History and Methods of This Evaluation; 14 Appendix B: A Chronology of the National Heart, Lung, and Blood Institute Artificial Heart Program and Related Events; 15 Appendix C: Technological Opportunities and Barriers in the Development of Mechanical Circulatory Support Systems; 16 Appendix D: Epidemiology of End-Stage Heart Disease; 17 Appendix E: Assessing the Cost-Effectiveness of the Development and Use of the Total Artificial Heart; 18 Glossary; 19 IndexReviewsAuthor InformationJohn R. Hogness and Malin VanAntwerp, Editors; Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute; Division of Health Care Services Tab Content 6Author Website:Countries AvailableAll regions |